Randomized Safety Study of CVT-301 Compared to an Observational Control Group

Clinical trial NCT02352363 · COMPLETED

Trial details

NCT number: NCT02352363
Sponsor: Acorda Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Parkinson's Disease

Start date: 2015-03-01
Primary completion: 2017-05-01
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.